FDA expands approval for spinal cord stimulator
By Admin | February 06, 2024
The FDA has approved Boston Scientific's WaveWriter SCS Systems for treating chronic low back and leg pain in people without prior back surgery.
Chronic back pain management in nonsurgical patients is often limited to conventional management such as physical therapy and medication.
Better pain management could help lead to improved quality of life and reduced opioid usage among patients, according to a Feb. 6 press release.
The expanded use by the FDA is backed by positive one-year data from a randomized control trial that demonstrated the...(More)
For more info please read, FDA expands approval for spinal cord stimulator, by Becker's Spine Review
